{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:03:13Z","timestamp":1778047393112,"version":"3.51.4"},"reference-count":175,"publisher":"Informa UK Limited","issue":"11","funder":[{"name":"unrestricted grant by GSK"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2021,11,2]]},"DOI":"10.1080\/21645515.2021.1971473","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T18:19:30Z","timestamp":1631729970000},"page":"4265-4282","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3205-9758","authenticated-orcid":false,"given":"Massimo","family":"Andreoni","sequence":"first","affiliation":[{"name":"UOC Infectious diseases Tor Vergata Polyclinic, University Hospital Viale, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7819-7400","authenticated-orcid":false,"given":"Laura","family":"Sticchi","sequence":"additional","affiliation":[{"name":"Hygiene Unit, Ospedale Policlinico San Martino-IRCCS, Genoa, Italy"},{"name":"Department of Health Sciences, University of Genoa, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Nozza","sequence":"additional","affiliation":[{"name":"Medical Director, San Raffaele Hospital, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loredana","family":"Sarmati","sequence":"additional","affiliation":[{"name":"UOC Infectious diseases Tor Vergata Polyclinic, University Hospital Viale, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gori","sequence":"additional","affiliation":[{"name":"UOC Infectious Diseases, Irccs Ca\u2019Granda Foundation, Maggiore Policlinico Hospital, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Tavio","sequence":"additional","affiliation":[{"name":"UOC Division of Emerging Infectious Diseases and Immunosuppressed, AOU Ospedali Riuniti of Ancona, Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Society for Infectious and Tropical Diseases (SIMIT)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"e_1_3_4_2_1","unstructured":"World Health Immunization (WHO). Vaccines and immunization; 2013 [accessed 2021 April 7]. https:\/\/www.who.int\/health-topics\/vaccines-and-immunization#tab=tab_1."},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040560"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.11.015"},{"key":"e_1_3_4_5_1","unstructured":"Centers for Disease Control and Prevention. Adults with health conditions; 2017 [accessed 2021 April 7]. https:\/\/www.cdc.gov\/features\/vaccineschronicconditions\/index.html."},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-018-0040-8"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2017.08.006"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.16205"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06651.x"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3547"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1033"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-017-0107-2"},{"key":"e_1_3_4_13_1","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the advisory committee on immunization practices (ACIP) and recommendation of ACIP, supported by the healthcare infection control practices advisory committee (HICPAC), for use of Tdap among health-care personnel","volume":"15","author":"Kretsinger K","year":"2006","unstructured":"Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the advisory committee on immunization practices (ACIP) and recommendation of ACIP, supported by the healthcare infection control practices advisory committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep. 2006;15:1\u201337.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1495565"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.014"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6703a5"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v44i09a06"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-019-02882-5"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30627-9"},{"key":"e_1_3_4_20_1","unstructured":"Center for Disease Control and Prevention. Recommended adult immunization schedule for ages 19 years or older United States; 2021 [accessed 2021 April 7]. https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/adult.html."},{"key":"e_1_3_4_21_1","unstructured":"European Centre for Disease Prevention and Control; 2021 [accessed 2021 April 7]. https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedDiseaseId=15&SelectedCountryIdByDisease=1."},{"key":"e_1_3_4_22_1","unstructured":"Italian National Health System (ISS). Calendario vaccinale [accessed 2021 April 7]. https:\/\/www.epicentro.iss.it\/vaccini\/calendario."},{"key":"e_1_3_4_23_1","unstructured":"National Health Service (UK). NHS vaccinations and when to have them [accessed 2021 April 7]. https:\/\/www.nhs.uk\/conditions\/vaccinations\/nhs-vaccinations-and-when-to-have-them\/."},{"key":"e_1_3_4_24_1","unstructured":"National Advisory Committee on Immunization (NACI). Statements and publications [accessed 2021 April 7]. https:\/\/www.canada.ca\/en\/public-health\/services\/immunization\/national-advisory-committee-on-immunization-naci.html."},{"key":"e_1_3_4_25_1","unstructured":"Statement of the German standing committee on vaccination at the RKI recommendations of the standing committee on vaccination (STIKO) at the Robert Koch Institute \u2013 2017\/2018 [accessed 2021 April 7]. https:\/\/www.rki.de\/EN\/Content\/infections\/Vaccination\/recommandations\/recommendations_node.html."},{"key":"e_1_3_4_26_1","unstructured":"European Centre for Disease Prevention and Control [accessed 2021 April 7]. https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=\u22121."},{"key":"e_1_3_4_27_1","unstructured":"European Centre for Disease Prevention and Control. [accessed 2021 April 7]. https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedDiseaseId=3&SelectedCountryIdByDisease=\u22121."},{"key":"e_1_3_4_28_1","unstructured":"European Centre for Disease Prevention and Control. [accessed 2021 April 7]. https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedDiseaseId=51&SelectedCountryIdByDisease=\u22121."},{"key":"e_1_3_4_29_1","unstructured":"Center for Disease Control and Prevention. COVID-19 ACIP vaccine recommendations. [accessed 2021 April 7]. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html."},{"key":"e_1_3_4_30_1","unstructured":"European Centre for Disease Prevention and Control. High-risk groups for COVID-19. [accessed 2021 April 7]. https:\/\/www.ecdc.europa.eu\/en\/covid-19\/high-risk-groups."},{"key":"e_1_3_4_31_1","unstructured":"Italian National Health System (ISS). Raccomandazioni ad interim sui gruppi target della vaccinazione anti SARS-CoV-2\/COVID-19 [accessed 2021 April 13]. https:\/\/www.epicentro.iss.it\/vaccini\/covid-19-piano-vaccinazione."},{"key":"e_1_3_4_32_1","unstructured":"National Health Service (UK). Coronavirus (COVID-19) vaccine [accessed 2021 April 13]. https:\/\/www.nhs.uk\/conditions\/coronavirus-covid-19\/coronavirus-vaccination\/coronavirus-vaccine\/."},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00041"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1086\/379048"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.562017"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2019.1588727"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1086\/656587"},{"key":"e_1_3_4_38_1","unstructured":"World Health Organization. Cardiovascular disease; 2020 [accessed 2021 April 13]. https:\/\/www.who.int\/health-topics\/cardiovascular-diseases\/#tab=tab_1."},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1159\/000493572"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201411-1951PP"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.07.038"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00199.2015"},{"key":"e_1_3_4_43_1","first-page":"334","article-title":"Influenza vaccination: a one-shot deal to reduce cardiovascular events","volume":"38","author":"Vardeny O","year":"2017","unstructured":"Vardeny O, Solomon SD. Influenza vaccination: a one-shot deal to reduce cardiovascular events. Eur Heart J. 2017;38:334\u201337.","journal-title":"Eur Heart J"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1086\/518849"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-0413-9"},{"key":"e_1_3_4_46_1","first-page":"15","article-title":"ACC health policy statement on cardiovascular disease considerations for COVID-19 vaccine prioritization","volume":"77","author":"American College of Cardiology","year":"2021","unstructured":"American College of Cardiology. ACC health policy statement on cardiovascular disease considerations for COVID-19 vaccine prioritization. J Am Coll Cardiol. 2021;77:15.","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy385"},{"key":"e_1_3_4_48_1","unstructured":"Center for Disease Control and Prevention. Recommended adult immunization schedule by medical condition and other indications United States 2021; 2021 [accessed 2021 April 13]. https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/adult-conditions.html."},{"key":"e_1_3_4_49_1","unstructured":"World Health Organization. Influenza position paper. [accessed 2021 April 13]. https:\/\/www.who.int\/immunization\/policy\/position_papers\/influenza\/en\/."},{"key":"e_1_3_4_50_1","unstructured":"European Centre for Disease Prevention and Control. Expert opinion on priority risk groups for influenza vaccination. [accessed 2021 April 13]. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/media\/en\/publications\/Publications\/0808_GUI_Priority_Risk_Groups_for_Influenza_Vaccination.pdf."},{"key":"e_1_3_4_51_1","unstructured":"Italian Ministry of Health. National immunization plan 2017-2019 [accessed 2021 April 13]. http:\/\/www.gazzettaufficiale.it\/eli\/id\/2017\/02\/18\/17A01195\/sg."},{"key":"e_1_3_4_52_1","unstructured":"Australian Government Department of Health. Pneumococcal vaccination for people with risk conditions for pneumococcal disease [accessed 2021 April 13]. https:\/\/immunisationhandbook.health.gov.au\/resources\/publications\/pneumococcal-vaccination-for-people-with-risk-conditions-for-pneumococcal."},{"key":"e_1_3_4_53_1","unstructured":"National Health Service (UK). Who is at high risk from coronavirus (clinically extremely vulnerable). Who is at high risk from coronavirus (clinically extremely vulnerable) \u2013 NHS [accessed 2021 April 13]. www.nhs.uk."},{"key":"e_1_3_4_54_1","first-page":"47","article-title":"Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis","volume":"23","author":"Mertz D","year":"2013","unstructured":"Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, Fadel SA, Tran D, Fernandez E, Bhatnagar N, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;23:47\u2013f5061.","journal-title":"BMJ"},{"key":"e_1_3_4_55_1","first-page":"28","article-title":"Two-year follow-up of the FLU vaccination acute coronary syndromes (FLUVACS) registry","volume":"31","author":"Gurfinkel EP","year":"2004","unstructured":"Gurfinkel EP, de la Fuente RL. Two-year follow-up of the FLU vaccination acute coronary syndromes (FLUVACS) registry. Texas Heart Inst J. 2004;31:28\u201332.","journal-title":"Texas Heart Inst J"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2013-304320"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.091891"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.071100"},{"key":"e_1_3_4_59_1","first-page":"CD005050","article-title":"Influenza vaccines for preventing cardiovascular disease","volume":"5","author":"Clar C","year":"2015","unstructured":"Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. 2015;5:CD005050.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-206780"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2016.11.014"},{"key":"e_1_3_4_62_1","unstructured":"Australian Institute of Health and Welfare. Vaccination uptake among people with chronic respiratory disease [accessed 2021 April 13]. https:\/\/www.aihw.gov.au\/reports\/chronic-respiratory-conditions\/vaccination-uptake-among-people-with-chronic-respi\/contents\/table-of-contents."},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.47.2.112"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80530-X"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1374"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1652517"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.017"},{"key":"e_1_3_4_68_1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. 2020 Global strategy for prevention diagnosis and management of COPD. [accessed 2021 May 4]. https:\/\/goldcopd.org\/gold-reports\/."},{"key":"e_1_3_4_69_1","unstructured":"Global Initiative for Asthma (GINA). 2021 GINA report global strategy for asthma management and prevention. [accessed 2021 May 4]. https:\/\/ginasthma.org\/gina-reports\/."},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.045187"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2010.02505.x"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12165"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e31826c2dda"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00070-7"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.112168"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268801006574"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1080\/02770900902795538"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.3.274"},{"key":"e_1_3_4_79_1","first-page":"CD002733","article-title":"Influenza vaccine for patients with chronic obstructive pulmonary disease","volume":"25","author":"Poole PJ","year":"2006","unstructured":"Poole PJ, Chacko E, Wood-Baker RW, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;25:CD002733.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.04.064"},{"key":"e_1_3_4_81_1","first-page":"12","article-title":"Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease","volume":"13","author":"Bornheimer R","year":"2017","unstructured":"Bornheimer R, Shea KM, Sato R, Weycker D, Pelton SI. Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease. PLoS One. 2017;13:12.","journal-title":"PLoS One"},{"key":"e_1_3_4_82_1","first-page":"CD001390","article-title":"Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease","volume":"24","author":"Walters JA","year":"2017","unstructured":"Walters JA, Tang JN, Poole P, Wood-Baker R. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;24:CD001390.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_83_1","article-title":"Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies","volume":"23","author":"Tin Tin Htar M","unstructured":"Tin Tin Htar M, Stuurman AL, Ferreira G, Alicino C, Bollaerts K, Paganino C, Reinert RR, Schmitt HJ, Trucchi C, Vestraeten T, et al. Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies. PLoS One. 201. 23.","journal-title":"PLoS One"},{"key":"e_1_3_4_84_1","first-page":"1","article-title":"Influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based review","volume":"12","author":"Sehatzadeh S","year":"2012","unstructured":"Sehatzadeh S. Influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based review. Ont Health Technol Assess Ser. 2012;12:1\u201364.","journal-title":"Ont Health Technol Assess Ser"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.05.037"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S140378"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-007-0118-3"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1177\/147323000503300503"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.11.020"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis627"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268817000887"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1080\/15412555.2021.1899155"},{"key":"e_1_3_4_93_1","first-page":"4927","article-title":"Late breaking abstract - Seroprevalence of Bordetella pertussis in chronic obstructive pulmonary disease (COPD) patients","volume":"56","author":"Mukherjee P","year":"2020","unstructured":"Mukherjee P, Cheuvart B, Baudson N, Dodet M, Turriani E, Harrington L, Meyer N, Rondini S, Taddei L, Den Steen PV. Late breaking abstract - Seroprevalence of Bordetella pertussis in chronic obstructive pulmonary disease (COPD) patients. Eur Respir J. 2020;56:4927.","journal-title":"Eur Respir J"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy889"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00083-15"},{"key":"e_1_3_4_96_1","first-page":"409","article-title":"Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model","volume":"12","author":"Ennis DP","year":"2005","unstructured":"Ennis DP, Cassidy JP, Mahon BP. Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model. Clin Diagn Lab Immunol. 2005;12:409\u201317.","journal-title":"Clin Diagn Lab Immunol"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.94253"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00379-4"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181f4e499"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-35"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.07.095"},{"key":"e_1_3_4_102_1","first-page":"E249","article-title":"Multi-disciplinary Consensus Statement document vaccinal prevention in adult patients with diabetes mellitus","volume":"15","author":"Icardi G","year":"2018","unstructured":"Icardi G, Francia F, Di Bartolo P, Mannino D, Alti E, Purrello F, Sesti G. Multi-disciplinary Consensus Statement document vaccinal prevention in adult patients with diabetes mellitus. J Prev Med Hyg. 2018;15:E249\u2013E256.","journal-title":"J Prev Med Hyg"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-3158-8"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-309983"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30238-2"},{"key":"e_1_3_4_106_1","unstructured":"Centers for Disease Control and Prevention. Diabetes Type 1 and Type 2 and adult vaccination. [accessed 2021 May 4]. https:\/\/www.cdc.gov\/vaccines\/adults\/rec-vac\/health-conditions\/diabetes.html."},{"key":"e_1_3_4_107_1","unstructured":"Australian Government Department of Health. People with medical risk conditions. [accessed 2021 May 4]. https:\/\/www.health.gov.au\/health-topics\/immunisation\/immunisation-throughout-life\/people-with-medical-risk-conditions."},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.1.95"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6701a1"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1177\/193229681200600417"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep36996"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.09.014"},{"key":"e_1_3_4_113_1","article-title":"Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysis","volume":"6","author":"H\u00e4rm\u00e4l\u00e4 S","year":"2019","unstructured":"H\u00e4rm\u00e4l\u00e4 S, Parisinos CA, Shallcross L, O\u2019Brien A, Hayward A. Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysis. BMJ Open. 2019;6.","journal-title":"BMJ Open"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-012-0300-6"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2020.06.006"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(02)03572-8"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit816"},{"key":"e_1_3_4_118_1","first-page":"1900","article-title":"Risk of hospitalization due to pneumococcal disease in adults in Spain. The CORIENNE study","volume":"2","author":"Gil-Prieto R","year":"2016","unstructured":"Gil-Prieto R, Pascual-Garcia R, Walter S, \u00c1lvaro-Meca A, Gil-De-Miguel \u00c1. Risk of hospitalization due to pneumococcal disease in adults in Spain. The CORIENNE study. Hum Vaccin Immunother. 2016;2:1900\u201305.","journal-title":"Hum Vaccin Immunother"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.02.017"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001053"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-018223"},{"key":"e_1_3_4_122_1","article-title":"Vaccinating adult patients with cirrhosis: trends over a decade in the United States","volume":"5795712","author":"Waghray A","year":"2016","unstructured":"Waghray A, Waghray N, Khallafi H, Menon KV. Vaccinating adult patients with cirrhosis: trends over a decade in the United States. Gastroenterol Res Pract. 2016;2016:5795712.","journal-title":"Gastroenterol Res Pract"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.08.032"},{"key":"e_1_3_4_124_1","first-page":"1","article-title":"Infections in patients with CRF","volume":"15","author":"Pesanti EL","year":"2001","unstructured":"Pesanti EL. Infections in patients with CRF. Infect Dis Clin North Am. 2001;15:1\u201315.","journal-title":"Infect Dis Clin North Am"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.944508"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)07239-6"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.08.079"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2018.02.186"},{"key":"e_1_3_4_129_1","unstructured":"The renal association. COVID-19 vaccination for adult patients with kidney disease: a position statement from the UK renal community. [accessed 2021 May 4]. https:\/\/renal.org\/health-professionals\/covid-19\/ra-resources\/covid-19-vaccination-adult-patients-kidney-disease."},{"key":"e_1_3_4_130_1","unstructured":"Getting the COVID-19 Vaccine. What kidney patients need to know. [accessed 2021 May 4]. https:\/\/www.kidney.org\/newsletter\/getting-covid-19-vaccine-what-kidney-patients-need-to-know."},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa314"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq853"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.874950"},{"key":"e_1_3_4_134_1","article-title":"Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study","author":"Wang IK","unstructured":"Wang IK, Lin CL, Lin PC, Liang CC, Liu YL, Chang CT, Yen TH, Morisky DE, Huang CC, Sung FC. Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study. PLoS One. 2013;8(3):e58317.","journal-title":"PLoS One"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.09.008"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12005"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29610"},{"key":"e_1_3_4_138_1","article-title":"COVID-19 vaccination: the VOICE for patients with cancer","volume":"27","author":"van der Veldt AAM","year":"2021","unstructured":"van der Veldt AAM, Oosting SF, Dingemans AC, Fehrmann RSN, GeurtsvanKessel C, Jalving M, Rimmelzwaan GF, Kvistborg P, Blank CU, Smit EF, et al. COVID-19 vaccination: the VOICE for patients with cancer. Nat Med. 2021;27(4):568\u2013569.","journal-title":"Nat Med"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30600-5"},{"key":"e_1_3_4_140_1","unstructured":"British Society of Blood and Marrow Transplantation and Cellular Therapy. BSBMTCT AND COVID. [accessed 2021 May 4]. https:\/\/bsbmtct.org\/bsbmtct-and-covid\/."},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annfar.2013.01.025"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/19.5.271"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2003.00158.x"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475418811335"},{"key":"e_1_3_4_145_1","unstructured":"Centers for Disease Control and Prevention. General best practice guidelines for immunization: best practices guidance of the advisory committee on immunization practices (ACIP). [accessed 2021 May 4]. https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/immunocompetence.html."},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13563"},{"key":"e_1_3_4_147_1","unstructured":"Health and Safety Executive HSE. Immunization guidelines chapter 3. [accessed 2021 May 4]. https:\/\/www.hse.ie\/eng\/health\/immunisation\/hcpinfo\/guidelines\/."},{"key":"e_1_3_4_148_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003523"},{"key":"e_1_3_4_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2020.12.009"},{"key":"e_1_3_4_150_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2014.0121"},{"key":"e_1_3_4_151_1","volume-title":"In: Statpearls [Internet]","author":"Ashorobi D","year":"2021","unstructured":"Ashorobi D, Fernandez R. In: Statpearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. [accessed 2021 May 3]. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538171\/."},{"key":"e_1_3_4_152_1","unstructured":"Societ\u00e0 Italiana Malattie Infettive. Linee Guida Italiane sull\u2019utilizzo dei farmaci antiretrovirali e sulla gestione diagnostico-clinica delle persone con infezione da HIV-1. [accessed 2021 May 4]. https:\/\/www.simit.org\/images\/documenti\/81-lineeguidahiv.pdf."},{"key":"e_1_3_4_153_1","unstructured":"ESMO Statements for vaccination against COVID-19 in patients with cancer. ESMO Statements for vaccination against COVID-19 in patients with cancer. [accessed 2021 May 4]. https:\/\/www.esmo.org\/content\/download\/402887\/7815383\/1\/Covid-19-Vaccinations-and-Patients-with-Cancer-An-ESMO-Call-to-Action.pdf."},{"key":"e_1_3_4_154_1","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","unstructured":"Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012;61:816\u201319.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_4_155_1","first-page":"521","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the advisory committee on immunization practices (ACIP)","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","unstructured":"Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 2013;62:521\u201324.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_4_156_1","unstructured":"Public Health England. 2013. The green book. Pneumococcal Chapter 25. [accessed 2021 May 4]. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/263318\/Green-Book-Chapter-25-v5_2.pdf."},{"key":"e_1_3_4_157_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13563"},{"key":"e_1_3_4_158_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.01964.x"},{"key":"e_1_3_4_159_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01565.x"},{"key":"e_1_3_4_160_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.22165"},{"key":"e_1_3_4_161_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.09.181"},{"key":"e_1_3_4_162_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12570"},{"key":"e_1_3_4_163_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-316586"},{"key":"e_1_3_4_164_1","first-page":"145","article-title":"Mortality in transplant recipients","volume":"11","author":"Alfishawy M","year":"2020","unstructured":"Alfishawy M, Elbendary A, Mohamed M, Nassar MCOVID-19. Mortality in transplant recipients. Int J Organ Transplant Med. 2020;11:145\u201362.","journal-title":"Int J Organ Transplant Med"},{"key":"e_1_3_4_165_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6818e1"},{"key":"e_1_3_4_166_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2018.00277"},{"key":"e_1_3_4_167_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-019-03563-w"},{"key":"e_1_3_4_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2012.06.068"},{"key":"e_1_3_4_169_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-019-00265-6"},{"key":"e_1_3_4_170_1","article-title":"Guiding principles for development of ACIP recommendations for vaccination during pregnancy and breastfeeding","volume":"57","author":"Advisory Committee on Immunization Practices Centers for Disease Control and Prevention (CDC)","year":"2008","unstructured":"Advisory Committee on Immunization Practices Centers for Disease Control and Prevention (CDC). Guiding principles for development of ACIP recommendations for vaccination during pregnancy and breastfeeding. MMWR Morb Mortal Wkly Rep. 2008;57.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_4_171_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.1658"},{"key":"e_1_3_4_172_1","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12355"},{"key":"e_1_3_4_173_1","article-title":"ACOG committee opinion No. 661: integrating immunizations into practice","author":"American College of Obstetricians and Gynecologists","year":"2016","unstructured":"American College of Obstetricians and Gynecologists. ACOG committee opinion No. 661: integrating immunizations into practice. Obstet Gynecol. 2016;127(4):e104\u2013e107.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_4_174_1","article-title":"Immunization and emerging infections expert work group. Committee opinion No. 718: update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination","author":"Committee on Obstetric Practice","year":"2017","unstructured":"Committee on Obstetric Practice. Immunization and emerging infections expert work group. Committee opinion No. 718: update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Obstet Gynecol. 2017;130(3):e153\u2013e157.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_4_175_1","unstructured":"National Health Service (UK). Vaccination for women who are planning pregnancy pregnant or breastfeeding [accessed 2021 May 4]. https:\/\/immunisationhandbook.health.gov.au\/vaccination-for-special-risk-groups\/vaccination-for-women-who-are-planning-pregnancy-pregnant-or."},{"key":"e_1_3_4_177_1","unstructured":"Centers for Disease Control and Prevention. Vaccination safety for breastfeeding mothers. [accessed 2021 May 4]. https:\/\/www.cdc.gov\/breastfeeding\/breastfeeding-special-circumstances\/vaccinations-medications-drugs\/vaccinations.html."}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1971473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T15:01:06Z","timestamp":1709305266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2021.1971473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":175,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,2]]}},"alternative-id":["10.1080\/21645515.2021.1971473"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2021.1971473","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}